Related Experiment Videos
Development of radiochemically pure antibodies
1Squibb Enstitute for Medical Research, New Brunswick, New Jersey 08903-0191.
Cancer Research
|February 1, 1990
Summary
Directly labeling antibodies or labeling a chelator after antibody conjugation yields impure results. For high radiochemical purity, prelabeling the chelating agent before antibody conjugation is the preferred radiolabeling method for technetium-99m labeled proteins.
Area of Science:
- Radiochemistry
- Immunology
- Bioconjugation
Background:
- Antibody-based radiopharmaceuticals are crucial for diagnostic imaging and targeted therapy.
- Achieving high radiochemical purity is essential for the efficacy and safety of radiolabeled antibodies.
- Current radiolabeling methods for antibodies present challenges in obtaining pure products.
Purpose of the Study:
- To evaluate different radiolabeling strategies for antibodies.
- To identify the optimal method for achieving high radiochemical purity of technetium-99m labeled proteins.
Main Methods:
- Comparison of three antibody radiolabeling approaches: direct radiolabeling, post-conjugation chelator labeling, and pre-conjugation chelator labeling.
- Assessment of radiochemical purity for each method using technetium-99m (99mTc).
Main Results:
- Direct radiolabeling of antibodies did not yield radiochemically pure 99mTc-labeled proteins.
- Radiolabeling of a chelating agent conjugated to an antibody also resulted in impure 99mTc-labeled proteins.
- Radiolabeling of a chelating agent before conjugation to an antibody achieved high radiochemical purity.
Conclusions:
- The prelabeled ligand method is superior for obtaining radiochemically pure 99mTc-labeled antibodies.
- This preferred method enhances the quality and potential clinical utility of antibody-based radiotracers.